Gutierrez-Rodrigues F, Sahoo S, Wlodarski M, Young N
Best Pract Res Clin Haematol. 2021; 34(2):101279.
PMID: 34404533
PMC: 8374086.
DOI: 10.1016/j.beha.2021.101279.
Langemeijer S, Schaap C, Preijers F, Jansen J, Blijlevens N, Inoue N
Blood Adv. 2020; 4(22):5755-5761.
PMID: 33216889
PMC: 7686886.
DOI: 10.1182/bloodadvances.2020002210.
Hochsmann B, Murakami Y, Osato M, Knaus A, Kawamoto M, Inoue N
J Clin Invest. 2019; 129(12):5123-5136.
PMID: 31430258
PMC: 6877298.
DOI: 10.1172/JCI123501.
Cooper J, Young N
Blood. 2017; 130(22):2363-2372.
PMID: 29046282
PMC: 5709788.
DOI: 10.1182/blood-2017-07-794362.
Grover S, Dhiman A, Garg B, Sood N, Narang V
J Lab Physicians. 2017; 9(3):207-209.
PMID: 28706392
PMC: 5496300.
DOI: 10.4103/0974-2727.208259.
Paroxysmal nocturnal haemoglobinuria.
Hill A, DeZern A, Kinoshita T, Brodsky R
Nat Rev Dis Primers. 2017; 3:17028.
PMID: 28516949
PMC: 7879566.
DOI: 10.1038/nrdp.2017.28.
Clonal hematopoiesis in acquired aplastic anemia.
Ogawa S
Blood. 2016; 128(3):337-47.
PMID: 27121470
PMC: 5054460.
DOI: 10.1182/blood-2016-01-636381.
Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.
Dumitriu B, Feng X, Townsley D, Ueda Y, Yoshizato T, Calado R
Blood. 2014; 125(4):706-9.
PMID: 25406353
PMC: 4304114.
DOI: 10.1182/blood-2014-10-607572.
Paroxysmal nocturnal hemoglobinuria.
Brodsky R
Blood. 2014; 124(18):2804-11.
PMID: 25237200
PMC: 4215311.
DOI: 10.1182/blood-2014-02-522128.
I walk the line: how to tell MDS from other bone marrow failure conditions.
Gondek L, DeZern A
Curr Hematol Malig Rep. 2014; 9(4):389-99.
PMID: 25079655
PMC: 4224968.
DOI: 10.1007/s11899-014-0224-3.
The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.
DeZern A, Sekeres M
Oncologist. 2014; 19(7):735-45.
PMID: 24899643
PMC: 4077450.
DOI: 10.1634/theoncologist.2014-0056.
Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.
Yuan X, Braunstein E, Ye Z, Liu C, Chen G, Zou J
Stem Cells Transl Med. 2013; 2(11):819-29.
PMID: 24113066
PMC: 3808197.
DOI: 10.5966/sctm.2013-0069.
Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.
Nowak J, Wozniak J, Mendek-Czajkowska E, Dlugokecka A, Mika-Witkowska R, Rogatko-Koros M
Cell Biochem Biophys. 2012; 65(3):321-33.
PMID: 23076633
PMC: 3601265.
DOI: 10.1007/s12013-012-9435-1.
Response of paroxysmal nocturnal hemoglobinuria clone with aplastic anemia to rituximab.
Raghupathy R, Derman O
Case Rep Hematol. 2012; 2012:106182.
PMID: 22937317
PMC: 3420688.
DOI: 10.1155/2012/106182.
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Pu J, Hu R, Mukhina G, Carraway H, McDevitt M, Brodsky R
Haematologica. 2012; 97(8):1225-33.
PMID: 22315493
PMC: 3409821.
DOI: 10.3324/haematol.2011.048215.
Acute myeloid leukemia developing in patients with autoimmune diseases.
Ramadan S, Fouad T, Summa V, Hasan S, Lo-Coco F
Haematologica. 2011; 97(6):805-17.
PMID: 22180424
PMC: 3366644.
DOI: 10.3324/haematol.2011.056283.
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes.
Hochsmann B, Rojewski M, Schrezenmeier H
Ann Hematol. 2011; 90(8):887-99.
PMID: 21359652
PMC: 3132386.
DOI: 10.1007/s00277-011-1177-4.
Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.
Yin C, Medeiros L, Bueso-Ramos C
Int J Lab Hematol. 2010; 32(5):461-76.
PMID: 20626469
PMC: 4452117.
DOI: 10.1111/j.1751-553X.2010.01246.x.
Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes.
Shichishima T, Ikeda K, Takahashi N, Kameoka J, Tajima K, Murai K
Int J Hematol. 2010; 91(4):602-10.
PMID: 20376581
DOI: 10.1007/s12185-010-0559-z.
Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells.
Visconte V, Raghavachari N, Liu D, Keyvanfar K, Desierto M, Chen J
Haematologica. 2009; 95(2):214-23.
PMID: 19679885
PMC: 2817023.
DOI: 10.3324/haematol.2009.011650.
